Professional Experience
Dr. Sachin Almel has been associated with Department of Medical Oncology, P. D. Hinduja National Hospital & Medical Research Centre, Mumbai since July 1995.
Educational Qualification:
1988 - M.B.B.S., South Gujarat University
1992 - M.D. (Internal Medicine), South Gujarat University
1995 - D.M. (Onco Medicine) , Gujarat University
Experience:
| Date | Post Held | Institute |
|---|---|---|
| 02.04.2000 onwards | Consultant Medical Oncologist | P. D. Hinduja National Hospital & Medical Research Centre, Mumbai |
| 20.01.1997 – 01.04.2000 | Associate Consultant | P.D. Hinduja National Hospital & Medical Research Centre, Mumbai |
| 07.07.1997 – 07.09.1997 | ‘Fellow’ Varoon Mahajan Memorial Trust Inc. | CORNELL University Medical College, New York, USA |
| 13.07.1995 – 19.01.1997 | Clinical Associate | P. D. Hinduja National Hospital & Medical Research Centre, Mumbai |
| 01.05.1995 – 12.07.1995 | Junior Lecturer | Gujarat Cancer & Research Institute, Ahmedabad, Gujarat |
| 30.01.1993 – 30.04.1995 | Resident Doctor in Medical Oncology | Gujarat Cancer & Research Institute, Ahmedabad, Gujarat |
| 01.09.1989 – 28.01.1993 | Resident Doctor in Internal Medicine | Government Medical College, Surat, Gujarat |
He has also been involved in various clinical trials conducted at the Institute, the most notable being the MCP-841 and MCP-842 trials in collaboration with National Cancer Institute, U.S.A. for Acute Leukemia and High Grade Non-Hodgkin's lymphomas. During his basic training in department of Internal Medicine, he has worked in-
- Department of Cardiology for 3 months
- Department of Pulmonary Diseases for 3 months
- Department of Nephrology for 3 months
He has also worked for 3 months in the casualty department and has an adequate knowledge of handling emergency cases.
Clinical Trials Experience:
No. of years of experience in clinical trials: 5 Years
- Project Title: A Randomized, Double-Blind, and Multicentere Study of xxx Compared with Zoledronic Acid (Zometa) in the Treatment of Bone Metastases in subjects with Prostrate Cancer
PI: DR ASHA KAPADIA
CO-PI: DR SACHIN V ALMEL
- Project Title: A Randomized phase 2 Trial of Double-Blind, Placebo Controlled xxx in Combination with Paclitaxel, as First Line Therapy in Women with HER2Negative Locally Recurrent or Metastatic Breast Cancer
PI: DR SACHIN ALMEL
CO-PI:DR ASHA KAPADIA
- Project Title: A Randomised, Double-Blind, Placebo-Controlled, Multicentre, Phase III Study of Post - Operative Adjuvant XXX or Placebo and Concurrent Chemoradiotherapy Followed by Maintenance XXX or Placebo Monotherapy in High-Risk Subjects with Resected Squamous Cell Carcinoma of Head and Neck (SCCHN).”
PI: DR SACHIN ALMEL
CO-PI: DR ASHA KAPADIA
- Project Title: A multicentere, open-label, phase II study of XXX XXX for efficacy and Safety in patients with Metastatic breast cancer
PI: DR SACHIN ALMEL
CO-PI: DR ASHA KAPADIA
- Project Title: A Randomized, Open-Label, Multicenter, Phase 3 Study of xxx Plus Standard Supportive Care versus Standard Supportive Care in Anemic Patients with Metastatic Breast Cancer Receiving Standard Chemotherapy
PI: DR SACHIN ALMEL
CO-PI: DR ASHA KAPADIA
- Project Title: A Phase 1b / 2 Trial of XXX or XXX in Combination with Platinum-based Chemotherapy as First-Line Treatment for Extensive Stage Small Cell Lung Cancer”
PI: DR SACHIN ALMEL
CO-PI: DR ASHA KAPADIA
- Project Title: A Phase 3, Randomized, Double-Blinded Study of xxxxxxxxxx and Best Supportive Care (BSC) Versus Placebo and BSC in the Treatment of Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Following Disease Progression on First-Line Platinum- or Fluoropyrimidine-Containing Combination Therapy
PI: DR SACHIN ALMEL
CO-PI: DR ASHA KAPADIA
- Project Title: A Phase 3, randomized, double-blind, placebo-controlled study of oral xxx in addition to best supportive care in patients with non-small cell lung cancer who have failed two or more prior treatment regimens
PI: DR SACHIN ALMEL
CO-PI: DR ASHA KAPADIA
- A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Phase 3 Study of xxxxxxxx as Adjuvant Treatment for Women with Early-Stage Breast Cancer at High Risk of Recurrence (D-CARE).
PI: DR SACHIN ALMEL
CO-PI: DR ASHA KAPADIA
ICH-GCP Training:
Has Received ICH-GCP Training at PI meet held at Bangkok on 26th and 27th July 2008
Clinical profile of cerebral Malaria: A study of 35 cases. Thesis presented for the Degree of M.D. in Internal Medicine, South Gujarat University, Surat
Patterns of relapse in acute leukemia: A study of 25 cases. Thesis presented to Gujarat University, Ahmedabad for the degree D.M. (Medical Oncology)
Presented paper (Poster presentation) on patterns of relapse in acute leukemia at the Indian Society of Hematology and Blood Transfusion (ISHBT) conference held in February 1995 at Indore
Co-authored a review article - 'Chemotherapy in Gastrointestinal Malignancies' -, which was accepted and published in Indian Journal of Medical & Pediatric Oncology
Co-authored a paper - 'Comparative study of CHOP v/s CNOP in high grade NHL' - published in Indian Journal of ISHBT conference held at Indore (Feb 1995)
Review article on the drug 2 - deoxycoformycin that was published in Indian Journal of Medical and Pediatric Oncology
Presented a paper - 'Hepatitis B in Hematological Malignancies held at the ISHBT conference held at Bombay in January 1993
Presented a paper (oral presentation) - 'Chronic, daily, oral administration of Etoposide in advanced, refractory malignancies' at the VIIth Biennial International Conference of Indian Society of Oncology, held at Lucknow in March 1996
ORAL PAPER PRESENTATION - 'Chronic, daily, oral administration of Etoposide in advanced, refractory malignancies' - at the 3rd International Conference of ASIAN CLINICAL ONCOLOGY SOCIETY (ACOS) held in Kunming, CHINA between 15th - 17th August, 1996
- Presented two oral papers at the IXth biennial conference of Indian Society of Medical & Pediatric Oncology, held at Madurai, India between 14-16th February, 1997
The two papers are as under:
i) Non-Candida albicans fungemia in neutropenic children: A report of 3 cases
ii) Tamoxifen induced endometrial pathology: A P.D. Hinduja National Hospital & Medical Research Centre experience
- Coauthor of the article “Motesanib or open-label bevacizumab, in combination with paclitaxel as first line treatment for HER-2- Negative locally recurrent or metastatic breast cancer: Phase 2, randomized, double-blind placebo-controlled study – The Lancet Oncology Volume 12 Issue 4, April II, Page 369-376
- Co-prepared the following lectures:
i) Interferons in Pediatrics - a lecture delivered by Dr. Asha Kapadia at Bai Jerbai Wadia Hospital in October 1995.
ii) Management of Burkitt's lymphoma - lecture delivered by Dr. Asha Kapadia at the CME in Hematology conducted at Bombay Hospital in May 1996.
iii) Tamoxifen induced endometrial changes - a lecture by Dr. Asha Kapadia at a conference held at Nanavati Hospital, Bombay in May 1995.
iv) Co-authored "Vancomycin resistant Enterococci - a case report' in the Indian Journal of Medical & Paediatric Oncology.
v) Co-authored "Tomudex in advanced colonic cancer - a case report and literature review' in the Indian Journal of Medical & Pediatric Oncology.
vi) Co-authored a review article on "Granulocytic Sarcomas" in the Indian Journal of Medical & Paediatric Oncology.
Paper on 'HIGH DOSE METHOTREXATE’: A review of 35 cycles in 9 patients was accepted for presentation at the UICC Conference held in RIO, BRAZIL between 25 - 29th August, 1998.
Paper on 'HIGH DOSE METHOTREXATE (HDMTX) : A review of 47 cycles in 111 patients was accepted for publication in the abstract book of SIOP conference held in MONTREAL, CANADA between 13th - 18th September, 1999. I was awarded a scholarship to attend this conference.
Attended the 39th Interscience conference on Antimicrobial Agents & chemotherapy held in San Franciso, California USA between 26th - 29th September, 1999.
Paper on GRANULOCYTIC SARCOMAS: A review of 4 cases' presented at the ASIA PACIFIC CANCER CONGRESS conference held in CHENNAI between 13th - 15th December, 1999.
Paper on 'Monoclonal Antibody therapy in metastatic breast cancer: A case report has been accepted for poster presentation at the ICON conference on 'Breast Cancer to be held on 17th - 19th February, 2000.
- Co-uthor for the article "Three dimensional conformal radiation therapy in prostate adenocarcinoma : survival and rectal toxicity in J Cancer Res Ther - March 2005, Volume 1, Issue 1 page 34 - 37.
Oncology, cancer, tumour, medical oncology, chemotherapy, malignancies, immunotherapy, sarcoma, bone marrow transplant, blood cancer, leukemia, stem cell, carcinoma
"@context ": "https://schema.org ",
"@type ": "Hospital ",
"name ": "P. D. Hinduja Hospital - ",
"image ": "https://www.hindujahospital.com/static/Logo-3570dad3506eee206a594d7e761b3a4a.svg ",
"@id ": "https://www.hindujahospital.com/ ",
"url ": "https://www.hindujahospital.com/ ",
"telephone ": "022 6924 8000 ",
"address ": {
"@type ": "PostalAddress ",
"streetAddress ": "Swatantryaveer Savarkar Rd, Mahim West, Mahim, ",
"addressLocality ": "Mumbai ",
"postalCode ": "400016 ",
"addressCountry ": "IN "
},
"openingHoursSpecification ": {
"@type ": "OpeningHoursSpecification ",
"dayOfWeek ": [
"Monday ",
"Tuesday ",
"Wednesday ",
"Thursday ",
"Friday ",
"Saturday "
],
"opens ": "08:00 ",
"closes ": "18:00 "
},
"department ": {
"name ": "Dr. Sachin Almel - Oncologist, Medical Oncology & Cancer Care Specialist in Mumbai ",
"url ": "https://www.hindujahospital.com/doctors/sachin-almel ",
"image ": "https://hinduja-prod-assets.s3.ap-south-1.amazonaws.com/s3fs-public/2022-03/Sachin%20Almel_0.png ",
"telephone ": "022 4510 8111 "
}
}